Clinical Trial

Targeted Temperature Management on Delayed Neurocognitive Recovery in Older Patients After Major Cancer Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
With aging population, more older patients will receive major surgery for cancer. Older patients are at increased risk of postoperative neurocognitive complications including delayed neurocognitive recovery (dNCR), which is associated with prolonged hospital stay, raised complications, and impaired quality of life. Intraoperative hypothermia occurs in 57.1%-78.6% of patients undergoing major cancer surgery, especially in the elderly. Studies show that intraoperative hypothermia suppresses immune function, interferes with anesthetic metabolism, and delays anesthesia emergence. All these may be correlated with the occurrence of early postoperative dNCR. This study aims to verify whether intraoperative targeted temperature management (target core temperature: 36.8°C) compared with conventional temperature management (core temperature: 35.5°C) can reduce the incidence of dNCR in older patients undergoing major cancer surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-17.
Trial Details
NCT Number NCT07655687
Lead Sponsor Peking University First Hospital
Collaborators: Peking University Shenzhen Hospital
Conditions Elderly Patients, Cancer Surgery, Hypothermia, Accidental, Targeted Temperature Management, Delayed Neurocognitive Recovery
Enrollment 1,512 participants
Start Date 2026-06
Primary Completion 2028-10 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-23